Peng, J., Xiao, J., Long, J., Huang, L., Li, Y., Liu, J., Zhang, H., Xie, D., Wang, W., Weng, C., Zhang, Z., Chai, X. (2025). Updated analysis of a phase 2 study of fruquintinib plus trifluridine/tipiracil (TAS-102) as third-line treatment in patients with metastatic colorectal adenocarcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.145